Literature DB >> 1614976

A novel method for determination of sterility of microcapsules and measurement of viability of encapsulated organisms.

K K Kwok1, D J Burgess.   

Abstract

A method of determining the viability of microencapsulated microorganisms (Bacillus Calmette Guerin) is reported. This method was also used to measure the effectiveness of aseptic production of microcapsules in maintaining the interior of the microcapsules free from contamination by microorganisms. This method is advantageous over conventional plating methodology, as plating can only determine external contamination of microcapsules and similar devices. It involves the detection of 14CO2, which is generated by the metabolism of 14C-labeled fatty acid in the growth medium by encapsulated microorganisms. The method depends on the semipermeable nature of the microcapsule walls, which allows passage of 14C-palmitic acid and 14CO2. BCG organisms encapsulated within an alginate-polylysine-alginate microcapsule (5-15 microns) (1) were shown to be viable, and no contaminating organism(s) was present. Methods suitable for the aseptic production and freeze drying of alginate-polylysine-alginate BCG microcapsules, which retain the viability of the organisms, are reported.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1614976     DOI: 10.1023/a:1015859406588

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  11 in total

1.  A modified semi-solid medium and technique for determining viability of BCG.

Authors:  S R ROSENTHAL; A H KENNIEBREW; N RAISYS
Journal:  Acta Tuberc Pneumol Scand       Date:  1962

2.  Production of 5-15 microns diameter alginate-polylysine microcapsules by an air-atomization technique.

Authors:  K K Kwok; M J Groves; D J Burgess
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

Review 3.  BCG as adjuvant immunotherapy for neoplasia.

Authors:  E M Hersh; J U Gutterman; G M Mavligit
Journal:  Annu Rev Med       Date:  1977       Impact factor: 13.739

4.  Immunopotentiation with BCG. I. Immune response to different strains and preparations.

Authors:  G B Mackaness; D J Auclair; P H Lagrange
Journal:  J Natl Cancer Inst       Date:  1973-11       Impact factor: 13.506

5.  Intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: effect of bacillus Calmette-Guerin viability on treatment results.

Authors:  D R Kelley; T L Ratliff; W J Catalona; A Shapiro; J M Lage; W C Bauer; E O Haaff; S M Dresner
Journal:  J Urol       Date:  1985-07       Impact factor: 7.450

6.  Automatable radiometric detection of growth of Mycobacterium tuberculosis in selective media.

Authors:  G Middlebrook; Z Reggiardo; W D Tigertt
Journal:  Am Rev Respir Dis       Date:  1977-06

7.  Radiometric detection of the metabolic activity of Mycobacterium tuberculosis.

Authors:  D M Cummings; D Ristroph; E E Camargo; S M Larson; H N Wagner
Journal:  J Nucl Med       Date:  1975-12       Impact factor: 10.057

8.  Reduction of bladder tumor growth in mice treated with intravesical Bacillus Calmette-Guérin and its correlation with Bacillus Calmette-Guérin viability and natural killer cell activity.

Authors:  A Shapiro; T L Ratliff; D M Oakley; W J Catalona
Journal:  Cancer Res       Date:  1983-04       Impact factor: 12.701

9.  Viability of freeze-dried Tice-substrain BCG by bioluminescent measurement of adenosine triphosphate.

Authors:  M F Shi; M E Klegerman; M J Groves
Journal:  Microbios       Date:  1989

10.  Microencapsulated islets as bioartificial endocrine pancreas.

Authors:  F Lim; A M Sun
Journal:  Science       Date:  1980-11-21       Impact factor: 47.728

View more
  1 in total

1.  Microencapsulation of Bifidobacterium animalis subsp. lactis and Lactobacillus acidophilus in cocoa butter using spray chilling technology.

Authors:  D L Pedroso; M Dogenski; M Thomazini; R J B Heinemann; C S Favaro-Trindade
Journal:  Braz J Microbiol       Date:  2014-01-15       Impact factor: 2.476

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.